Boy was I wrong when I wrote that momentum stocks would rise again at the end of March. Since that article ran on March 29, the iShares MSCI USA Momentum Factor ETF (MTUM) has fallen 1.7%, while the SPDR S&P 500 ETF (SPY) has gained 0.2%. But there’s one part of that column I’m feeling o.k. about–Humana (HUM).
Now, Humana is not generally thought of as a momentum stock, but when I wrote that column it had been exactly that–one of the best performing stocks of the past year. It had a tough time during the momentum meltdown–Humana’s shares had dropped 2.6%–but its jumped after releasing earnings today and Humana has now gained 3.7%.
How good were Humana’s earnings? Humana reported a profit of $2.35 a share, beating forecasts for $1.94, on sales of $11.71 billion, topping the Street consensus for $11.52 billion. Cantor Fitzgerald’s Joseph D. France digs in:
Humana reported substantially better-than-expected 1Q:14 results, largely because utilization remains low, although $297 million of favorable development also helped…We expected that the chief headwinds in 2014 would be tough comparisons with favorable development, which as at record levels in 2013, and higher utilization, but there is little evidence of either so far…Management did not raise earnings guidance, but it did raise the enrollment outlook, and we expect the new business development and startup costs that weighed on the company in 1Q:14 will moderate over the balance of the year.
Best Gas Stocks To Buy Right Now: Alere Inc (ALR)
Alere Inc., incorporated on May 11, 2001, is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�� segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.
Professional Diagnostics
Professional diagnostics are generally designed to assist medical professionals in both preventative and interventional medicine, and include testing and monitoring performed in hospitals, laboratories and doctors' offices and, increasingly, patient self-testing, which the Company defines as testing or monitoring performed at home under the supervision of a medical professional. Professional diagnostic products provide for qualitative or quantitative analysis of patient samples for evidence of a specific medical condition, disease state or toxicological state or to measure response to therapy. The point-of-care market for rapid diagnostic products includes all areas where a patient is assessed or diagnosed, including hospitals, laboratories, physician offices, specialized mobile clinics, emergency rooms, rapid-response laboratories and patient health screening locations.
The Company's Alere Cholestech LDX System is a point-of-care monitor of blood cholesterol and related lipids which is used to test patients at risk of, or suffering from, heart disease and related conditions. The Alere Cholestech LDX System makes it possible to provide ! a complete lipid profile with tests for total cholesterol, high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), triglycerides, and glucose. The Company's Alere INRatio System is an easy-to-use, hand-held blood coagulation monitoring system for use by patients and healthcare professionals in the management of warfarin, a commonly prescribed medication used to prevent blood clots. The Company also offers the epoc Blood Analysis System for bloods gas, electrolyte and metabolite testing, which is manufactured by its recently acquired Epocal division. The epoc (enterprise point-of-care) platform is a point-of-care analysis system which provides Wireless bedside blood gas, electrolyte and metabolite measurement testing solutions and complements the Company's Alere Triage products in cardiology and emergency room settings.
The Company develops and markets a range of point-of-care tests for influenza A/B, RSV, strep throat, pneumonia, C. difficile, infectious mononucleosis, HIV, herpes simplex virus (HSV-2), hepatitis C (HCV), hepatitis B (HBV), malaria, lyme disease, Chlamydia, H. pylori, rubella and other infectious diseases. The Company's tests for infectious disease are sold under brand names that include Alere, Alere Determine, Acceava, BinaxNOW, Clearview, DoubleCheckGold, Panbio, SD, TECHLAB and Alere TestPack. In addition to point-of-care products, the Company also offers a line of indirect fluorescent antibody, or IFA, assays for over 20 viral, bacterial and autoimmune diseases, a full line of serology diagnostic products covering a range of disease categories and over 50 enzyme-linked immunosorbent assay (ELISA), tests for a range of infectious and autoimmune diseases, as well as a full line of automated instrumentation for processing ELISA tests.
The Company offers laboratory-based testing services throughout Europe under the name Alere Toxicology, formerly Concateno, and in the United States under the names Alere Toxicology Services, or! Alere To! xicology, and Redwood Toxicology Laboratory, or Redwood. The Company offers point-of-care diabetes products, including its Afinion Analyzer System and its NycoCard System. The Company's Alere Connect products include HealthPAL and HealthCOM.
Health Information Solutions
The Company's health information solutions are designed to provide physicians with actionable data that allows them to make more decisions in real time, deliver quality care, and put the individuals they treat on a pathway to better health. The Company offers a range of software-based analytics, clinical decision support tools, and accountable cares programs that enable healthcare providers to initiate earlier interventions, personalize treatment plans, lower costs by reducing hospital readmissions, and measure improvements in outcomes at both a patient and population level. With this range of scalable solutions, the Company is able to support healthcare practitioners in the transition to accountable care, as well as in meeting the new pay-for-performance guidelines set by the Centers for Medicare & Medicaid Services (CMS).
The Company's Women's and Children's Health division delivers a range of obstetrical care services that range from risk assessments focused on identifying women who may experience pregnancy complications to a neonatal program that supports early infant care management. The Company offers home-based obstetrical monitoring for pregnant women with medical or pregnancy-related problems that could puts their health or the health of their babies at risk. The Company also delivers telephonic and home-based nursing services that support improved clinical outcomes. The Company offers a suite of integrated wellness programs and resources that is designed to reduce participant health risks and healthcare-related costs. The Company's wellness programs include screening for risk factors associated with chronic disease, particularly tobacco use, poor nutrition, physical inactivity, and chron! ic stress! .
The Company offers services designed to support anticoagulation management for patients who takes warfarin to control their risk for stroke and clotting disorders. Alere Home Monitoring, the Company's patient self-testing business, assists patients in acquiring home INR monitors and with insurance coverage determinations and provides physicians with a comprehensive model that allows them to incorporate patient self-testing into their practices.
Consumer Diagnostics
The Company's consumer diagnostic products consist of the Company's First Check brand of over-the-counter drug tests for at-home testing for up to seven illicit drugs and five prescription drugs, as well as First Check brand over-the-counter tests for cholesterol monitoring. The Company also sells Balance Activ Vaginal Gel directly to consumers and healthcare professionals for the treatment of bacterial vaginosis without antibiotics.
The Company competes with Abbott, Siemens, Beckman Coulter, Johnson & Johnson, Roche, Abaxis Medical Diagnostics, International Technidyne Corporation, INOVA Diagnostics, DiaSorin, Diamedx and Qiagen.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Alere (NYSE: ALR ) , whose recent revenue and earnings are plotted below.
5 Best Performing Stocks To Watch For 2014: American Apparel Inc (APP)
American Apparel, Inc. incorporated on July 22, 2005, is a vertically integrated manufacturer, distributor, and retailer of branded fashions basic apparel and accessories for women, men, children and babies. As of January 31, 2013, the Company had operated 251 retail stores in 20 countries. The Company also operates an e-commerce site that serves over 60 countries worldwide at www.americanapparel.com . In addition, American Apparel operates a business that supplies T-shirts and other casual wear to distributors and the imprintable industry. The Company operates in four business segment: U.S. Wholesale, U.S. Retail, Canada, and International.
The U.S. Wholesale segment consists of the Company's wholesale operations of sales of undecorated apparel products to distributors and third party screen printers in the United States, as well as its online consumer sales to United States customers. The U.S. Retail segment consists of the Company's retail store operations in the United States. The Canada segment consists of the Company's retail, wholesale and online consumer operations in Canada. As of December 31, 2012 , the retail operations in the Canada segment consisted of 35 retail stores. The International segment consists of the Company's retail, wholesale and online consumer operations outside of the United States, and Canada. As of December 31, 2012 , the retail operations in the International segment were consisted of 76 retail stores.
As of December 31, 2012 , the Company's retail operations consisted of 251 retail stores in 20 countries, including the United States, Canada, Mexico, Brazil, United Kingdom, Ireland, Austria, Belgium, Germany, France, Italy, the Netherlands, Spain, Sweden, Switzerland, Israel, Australia, Japan, South Korea and China. The Company's wholesale operations sell to over a dozen authorized distributors and approximately 10,000 screen printers and advertising specialty companies. The Company operates 12 online stores in the United States, Canada, the U! nited Kingdom, Continental Europe, Switzerland, Japan, South Korea, Australia, Mexico, Brazil, Singapore and Hong Kong.
The Company competes with The Gap, Urban Outfitters, H&M, Uniqlo, Forever 21, Gildan Activewear, HanesBrands, Russell Athletic and Fruit of the Loom.
Advisors' Opinion:- [By Cristina Alesci and Catherine Tymkiw]
Charney, who founded American Apparel (APP) in 1998, was ousted by the board last week.
According to sources familiar with the situation, Charney was given two options: either step aside quietly and take a creative role that would pay around $1 million a year, or face being fired with cause.
- [By Melvin Backman]
American Apparel (APP) shares are over 1% higher this morning on rumors that the company make be a potential takeover target. It's the latest twist impacting the brand. Last week the company fired controversial CEO Dov Charney. Now Charney has fired back, writing a letter to the board challenging his dismissal. The company continues to struggle to turn around its brand. The stock is trading for less than $1.
- [By Ben Levisohn]
Normally I wouldn’t write about a stock that trades under a buck, but since we’re talking about American Apparel (APP), I guess I can make an exception. Today, news broke that controversial Dov Charney is out as CEO from the company he founded.
- [By WWW.DAILYFINANCE.COM]
Dominik Pabis/Getty Images Do you want to buy clothes that are made in America? And are you willing to pay what it costs to help bring manufacturing jobs back to America -- and be once again able to buy quality goods that will last, in return for your money? Words and Actions Most Americans answer yes to the first question -- initially, at least. A New York Times poll last year found 46 percent of shoppers saying they would happily pay the same price -- or even a bit of a premium -- to own clothing made in America, as opposed to clothing made in China, Vietnam or another foreign country. Yet according to American-made apparel manufacturer Buck Mason, less than 3 percent of clothing is made in America. Why is this? Many products made in America sell for prices far higher than what similar products made elsewhere cost. What's more, even if you are willing to pay the premium for quality (the Times poll noted that 56 percent of Americans say American-made clothing is of higher quality than imports), Buck Mason laments: "it is virtually impossible to go to a mall anywhere, and find a high-quality, American-made garment" today. So there are really two problems for shoppers looking to "buy American" today. First, you can't find such goods to buy. Second, if you do find them, they cost too much. American Apparel One company trying to fix the first problem is Los Angeles-based American Apparel (APP). A vertically integrated clothing company (meaning it owns and operates its own retail stores, selling its own clothing), American Apparel makes its clothing in the U.S. and sells it here and abroad. Despite charging prices that can be twice the cost of imports, however, American Apparel has struggled to earn a profit. The company ran into difficulties with its financial auditor in 2010 and suffered through a Securities and Exchange Commission investigation as a result. Sales growth has been anemic; American Apparel is losing money; and at last report, the company wa
5 Best Performing Stocks To Watch For 2014: Yongye International Inc.(YONG)
Yongye International, Inc. engages in the research, development, manufacture, and sale of fulvic acid based crop and animal nutrient products for the agriculture and stock farming industry in the People?s Republic of China. It provides liquid crop nutrient products that consist of fulvic acid compound base and nutrients for the health of crops; and powder animal nutrient products, which include fulvic acid compound base and additional nutrients, and Chinese herbs that reduce inflammation for dairy cows The company markets its products under the Shengmingsu trade name through a network of county-level distributors and independently owned branded retailers. Yongye International, Inc. is based in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By Lisa Levin]
Yongye International (NASDAQ: YONG) shares touched a new 52-week high of $6.97 after the company accepted a revised go private bid at $7.10 per share.
5 Best Performing Stocks To Watch For 2014: Tupperware Corporation(TUP)
Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions for the kitchen and home, as well as kitchen cookware and tools, children?s educational toys, microwave products, and gifts under the Tupperware brand name primarily in Europe, Africa, the Middle East, the Asia Pacific, and North America. The company provides beauty and personal care products, which include skin care products, cosmetics, bath and body care, toiletries, fragrances, nutritional products, apparel, and related products principally in Mexico, South Africa, the Philippines, Australia, and Uruguay. It offers beauty and personal care products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, Nuvo, and Swissgar de brand names. The company sells its Tupperware products directly to distributors, directors, managers, and dealers; and beauty products primarily through consultants and directors. As of December 26, 2009, the Tupperware distribution system had approximately 1,800 distributors, 61,300 managers, and 1.3 million dealers; and the sales force representing the Beauty businesses approximately 1.1 million. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. The company was founded in 1996 and is headquartered in Orlando, Florida.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Herbalife have gained 0.9% to $79.51 this morning in pre-open trading. Its shares have gained 139% this year, a nice gain, but lagging Nu Skin Enterprises 271% rise. Avon Products�(AVP), another multi-level marketer, has gained 21% so far this year, while Tupperware Brands�(TUP) has risen 49%.
- [By Johanna Bennett]
Corporate earnings took a back seat today to the Fed�� latest policy decision. Still, quarterly financial results, and other news sent shares of McCormick & Co. (MKC) and Tupperware (TUP), falling during regular market hours�Here�� a rundown of several of today�� moves:
- [By Jonathan Berr]
Multilevel marketing (MLM) groups such as Herbalife operate through independent sales representatives, who earn money both through the sales of product and by recruiting other people to join their team. This business model — which is used by scores of companies, including�Pampered Chef, which is owned by Warren Buffett’s Berkshire Hathaway (BRK.B), Tupperware (TUP) and Mary Kay Cosmetics — is legal provided that actual products are sold.
- [By James Brumley]
CSCO stock might be one of the market’s dark-horse stories of 2014; the dividend yield is the icing on the cake.
Dividend Stocks to Buy: Tupperware Brands (TUP)Dividend Yield: 3.2%
No comments:
Post a Comment